Results 211 to 220 of about 72,711 (261)

Improvement of the Anticancer Efficacy of PD‐1/PD‐L1 Blockade: Advances in Molecular Mechanisms and Therapeutic Strategies

open access: yesMedComm, Volume 6, Issue 8, August 2025.
Mechanisms of alleviating resistance to PD‐1/PD‐L1 blockade by IFN‐α and IFN‐β. In these mechanisms, the “yin‐yang balance” is disrupted, thus preventing T cells from attacking cancer cells. Restoring this balance may improve the efficacy of anti‐PD‐1/PD‐L1 therapy and reinvigorate T cells and other immune cells to target and destroy cancer cells ...
Peng Gao   +7 more
wiley   +1 more source

Characterization of Murine Leukemia Virus-specific Proteins

open access: yesCold Spring Harbor Symposia on Quantitative Biology, 1974
H. Ikeda   +9 more
openaire   +3 more sources

PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment

open access: yesMedComm, Volume 6, Issue 8, August 2025.
The PI3K/AKT/mTOR signaling axis is crucial in cancer progression, regulating cell growth, survival, and metabolism. Often hyperactivated through mutations or loss of tumor suppressors such as PTEN, this pathway promotes cancer cell proliferation and survival by inhibiting apoptosis and activating mTOR, which drives protein synthesis and suppresses ...
Mingyang Jiang   +10 more
wiley   +1 more source

Sequential activation of the three protomers in the Moloney murine leukemia virus Env. [PDF]

open access: yesProc Natl Acad Sci U S A, 2017
Sjöberg M   +3 more
europepmc   +1 more source

Dynein Regulators Are Important for Ecotropic Murine Leukemia Virus Infection. [PDF]

open access: yesJ Virol, 2016
Valle-Tenney R   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy